Atıf Formatları
Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10rir
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

F. Altındağ, "Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10rir," Journal of Experimental and Clinical Medicine , vol.39, no.1, pp.216-220, 2022

Altındağ, F. 2022. Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10rir. Journal of Experimental and Clinical Medicine , vol.39, no.1 , 216-220.

Altındağ, F., (2022). Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10rir. Journal of Experimental and Clinical Medicine , vol.39, no.1, 216-220.

Altındağ, Fikret. "Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10rir," Journal of Experimental and Clinical Medicine , vol.39, no.1, 216-220, 2022

Altındağ, Fikret. "Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10rir." Journal of Experimental and Clinical Medicine , vol.39, no.1, pp.216-220, 2022

Altındağ, F. (2022) . "Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10rir." Journal of Experimental and Clinical Medicine , vol.39, no.1, pp.216-220.

@article{article, author={Fikret Altındağ}, title={Silymarin ameliorates cisplatin-induced nephrotoxicity by downregulating TNF-α and NF-kB and by upregulating IL-10rir}, journal={Journal of Experimental and Clinical Medicine}, year=2022, pages={216-220} }